News & Updates

Pregnant women who are being treated with ustekinumab or vedolizumab appear to experience no greater complications as those receiving antitumour necrosis factor (anti-TNF) agents, immunomodulators, or combination anti-TNF/immunomodulators, according to a study.

Use of either adalimumab or infliximab as first antitumour necrosis factor (anti-TNF) agent results in positive outcomes among children with Crohn’s disease (CD), a study has shown.

Morphine appears to effectively palliate cough in patients with idiopathic pulmonary fibrosis (IPF), findings from the phase II PACIFY COUGH crossover trial suggest.

Treatment with upadacitinib, an oral selective Janus kinase inhibitor, led to greater proportions of days spent with improved nighttime itch and sleep disturbance experienced by patients with moderate-to-severe atopic dermatitis (AD), according to an integrated analysis of the phase III Measure Up 1 and 2 studies presented at AAD 2024.

How children in Singapore meet sleep, screen time, and physical activity recommendations appears to slip as they transition from infants to screen-focused toddlers and preschoolers, according to a study.